Respiratory Disease Genetic Testing Market Size, Share & Trends Analysis Report By Offerings (Products (Kits and Consumables), Services, Others), By Disease Type, By Offerings (PCR, NGS (Whole Genome Sequencing, Whole Exome Sequencing), Others, By Trait Type (Inherited Trait, Acquired Trait), By Age Group, By End-User, By Region, And By Segment Forecasts, 2023-2031

Report Id: 2217 Pages: 179 Last Updated: 29 October 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Respiratory Disease Genetic Testing Market-

By Offerings

  • Products
    • Kits and Consumables
  • Services
  • Others

Respiratory Disease Genetic Testing Market Seg

By Disease Type

  • COPD (Alpha-1-antitrypsin (AAT)
  • Cystic Fibrosis (CF)
  • Diffuse Lung Disease/Surfactant Dysfunction
    • RHD (Respiratory Distress Syndrome)
    • PPHN (Persistent Pulmonary Hypertension of the Newborn)
  • Interstitial lung disease
  • Pulmonary Arterial Hypertension
  • Pulmonary Hypoplasia
  • Primary Ciliary Dyskinesia
  • Other Diseases (BPD)

By Technology

  • PCR
  • NGS
    • Whole Genome Sequencing
    • Whole Exome Sequencing
  • Others (Targeted Sequencing, Karyotyping, and FISH)

By Trait Type

  • Inherited Trait
  • Acquired Trait

By Age Group

  • Children
  • Adult

By End-User

  • Hospital Laboratories
  • Diagnostics Laboratories
  • Genetic Testing Laboratories
  • Research Laboratories
  • Other End User

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Respiratory Disease Genetic Testing Market Snapshot

Chapter 4. Global Respiratory Disease Genetic Testing Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Trait Type Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis

5.1. By Offering, & Market Share, 2020 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Offering:

5.2.1. Products

5.2.1.1. Kits and Consumables

5.2.2. Services

5.2.3. Others

Chapter 6. Market Segmentation 2: By Specialty Type Estimates & Trend Analysis

6.1. By Specialty Type & Market Share, 2020 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Specialty Type:

6.2.1. COPD (Alpha-1-antitrypsin (AAT)

6.2.2. Cystic Fibrosis (CF)

6.2.3. Diffuse Lung Disease/Surfactant Dysfunction

6.2.3.1. RHD (Respiratory Distress Syndrome)

6.2.3.2. PPHN (Persistent Pulmonary Hypertension of the Newborn)

6.2.4. Interstitial lung disease

6.2.5. Pulmonary Arterial Hypertension

6.2.6. Pulmonary Hypoplasia

6.2.7. Primary Ciliary Dyskinesia

6.2.8. Other Diseases (BPD)

Chapter 7. Market Segmentation 3: By Trait Type Estimates & Trend Analysis

7.1. By Trait Type & Market Share, 2020 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Trait Type:

7.2.1. Inherited Trait

7.2.2. Acquired Trait

Chapter 8. Market Segmentation 4: By Test Type Technology Estimates & Trend Analysis

8.1. By Test Type Technology & Market Share, 2020 & 2031

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Test Type Technology:

8.2.1. PCR

8.2.2. NGS

8.2.2.1. Whole Genome Sequencing

8.2.2.2. Whole Exome Sequencing

8.2.3. Others (Targeted Sequencing, Karyotyping, and FISH)

Chapter 9. Market Segmentation 5: By Age Group Estimates & Trend Analysis

9.1. By Age Group & Market Share, 2020 & 2031

9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Age Group:

9.2.1. Children Age Group

9.2.2. Adult Age Group

Chapter 10. Market Segmentation 6: By End User Estimates & Trend Analysis

10.1. By End User & Market Share, 2020 & 2031

10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:

10.2.1. Hospital Laboratories

10.2.2. Diagnostics Laboratories

10.2.3. Genetic Testing Laboratories

10.2.4. Research Laboratories

10.2.5. Other End User

Chapter 11. Respiratory Disease Genetic Testing Market Segmentation 7: Regional Estimates & Trend Analysis

11.1. North America

11.1.1. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Offering, 2019-2031

11.1.2. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Specialty Type, 2019-2031

11.1.3. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Trait Type, 2019-2031

11.1.4. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Test Type Technology, 2019-2031

11.1.5. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Age Group, 2019-2031

11.1.6. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031

11.1.7. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

11.2. Europe

11.2.1. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, 2019-2031

11.2.2. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, 2019-2031

11.2.3. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, 2019-2031

11.2.4. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, 2019-2031

11.2.5. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, 2019-2031

11.2.6. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, 2019-2031

11.2.7. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031

11.3. Asia Pacific

11.3.1. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, 2019-2031

11.3.2. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, 2019-2031

11.3.3. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, 2019-2031

11.3.4. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, 2019-2031

11.3.5. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, 2019-2031

11.3.6. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, 2019-2031

11.3.7. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031

11.4. Latin America

11.4.1. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, (US$ Million) 2019-2031

11.4.2. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, (US$ Million) 2019-2031

11.4.3. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, (US$ Million) 2019-2031

11.4.4. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, (US$ Million) 2019-2031

11.4.5. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031

11.4.6. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User (US$ Million) 2019-2031

11.4.7. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031

11.5. Middle East & Africa

11.5.1. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, (US$ Million) 2019-2031

11.5.2. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, (US$ Million) 2019-2031

11.5.3. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, (US$ Million) 2019-2031

11.5.4. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, (US$ Million) 2019-2031

11.5.5. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031

11.5.6. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, (US$ Million) 2019-2031

11.5.7. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031

Chapter 12. Competitive Landscape

12.1. Major Mergers and Acquisitions/Strategic Alliances

12.2. Company Profiles

12.2.1. 23andMe, Inc.

12.2.2. Centogene A.G.

12.2.3. GeneDx, Inc.

12.2.4. Invitae Corporation

12.2.5. Color Genomics

12.2.6. Myriad Genetics

12.2.7. Medicover Genetics

12.2.8. Blueprint Genetics

12.2.9. Prevention Genetics

12.2.10. Quest Diagnostics

12.2.11. Genesis Genetics

12.2.12. ARUP Laboratories

12.2.13. EGL Genetic Diagnostics

12.2.14. Laboratory Corporation of America Holdings (LabCorp) 

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
8405
Security Code field cannot be blank!

Frequently Asked Questions

Respiratory Disease Genetic Testing Market Size is predicted to witness a 5.34% CAGR during the forecast period for 2023-2031.

Genesis Genetics, ARUP Laboratories, EGL Genetic Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Others

Offerings, disease type, technology, trait type, age group and end-user are the key segments of the Respiratory Disease Genetic Testing Market.

North American region is leading the Respiratory Disease Genetic Testing Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying